Uncategorized

Good news for plans sponsors who want to reduce their prescription drug costs: generics will continue to be used instead of brands. Bad news: these generics will continue to escalate in cost! The huge jump in many generics during 2014 was not a one-time anomaly.   We expect that generics will continue to rise, and coupled […]

The future of the Affordable Care Act (“ACA” or “Obamacare”) is hinging on the outcome of King v. Burwell. The Supreme Court is expected to rule before the end of June and 6.5 million folks who currently receive subsidies, are nervously awaiting the decision. The promise of healthcare reform, i.e., that the uninsured would receive […]

A new report by IMS Institute for Healthcare Information announces U.S drug spending during 2014 at a record $374 billion. The record spend represented a 13% increase over 2013.  This should come as no surprise to prescription drug plan sponsors trying to control and reduce prescription drug costs.  They’ve watched as the predictions regarding specialty […]